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Abstract
Background: There is increasing interest in actively involving patients in the process of medical research to help
ensure research is relevant and important to both researchers and people affected by the disease under study. This
project examined the recently formed Vasculitis Patient-Powered Research Network (VPPRN), a rare disease research
network, to better understand what investigators and patients learned from working on research teams together.
Methods: Qualitative interviews were conducted by phone with patients, physician/PhD-investigators, and study
managers/staff who participated in the network. The question guiding the interviews and observational analysis
was: “What have investigators and patients learned about working together while working on VPPRN teams?”
Interview transcripts were analyzed in combination with observations from multiple in-person and telephone
meetings.
Results: Transcripts and notes were reviewed and coded from 22 interviews conducted among 13 patient-partners, 5
study managers/staff, and 4 MD or PhD-investigators, and 6 in-person and 42 telephone/web-conference meetings.
Patient-partners and investigators characterized their working relationships with one another, what they learned from
their collaborations, and provided recommendations for future teams of patient-partners and investigators. Major
themes included the great benefits of communicating about activities, being open to listening to each group
member, and the importance of setting reasonable expectations.
Conclusions: Direct engagement in research design and development by patient-partners and co-learning
between investigators and patient-partners can result in a positive and productive working relationship for all
members of a medical research team. This bi-directional engagement directly benefits and impacts research
design, participant recruitment to studies, and study subject retention.
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Background
There is increasing interest in actively involving patients in
the process of medical research to help ensure research is
relevant and important to both investigators and people
affected by the disease under study. Increasing attention
has recently been paid to examining patient engagement
in health care research [1]. The Patient-Centered Out-
comes Research Institute (PCORI) defines patient engage-
ment as “The meaningful involvement of patients,
caregivers, clinicians, and other healthcare stakeholders
throughout the entire research process—from planning
the study, to conducting the study, and disseminating
study results” (https://www.pcori.org/about-us/our-pro-
grams/engagement/value-engagement). Patient engage-
ment may be especially important for the study of rare
diseases in which the number and size of research studies
are relatively small, and the added benefit of more targeted
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outcomes and facilitated recruitment that patient research
partners can add is particularly advantageous. Research on
patient engagement has rarely incorporated qualitative
methods that involve participants who are directly in-
volved in the research process [2].
This study examined patient engagement in the develop-
ment and implementation of the recently-formed Vasculitis
Patient-Powered Research Network (VPPRN), a rare dis-
ease research network, to better understand what investiga-
tors and patients learned from working on research teams
together. The process and structural framework for en-
gaging patients in research with the VPPRN included: 1) es-
tablishing network governance policies and structure that
listens to the voices of all stakeholders including patients,
physicians, investigators, patient advocacy groups; 2)
empowering patients and other stakeholders to take on
leadership roles and participate at different levels, optimiz-
ing patient and stakeholder expertise, time, and interest; 3)
harnessing the broad influence of multi-stakeholder expert-
ise and addressing training needs of all stakeholders.
“Patient-partners” include patients, family members, care-
givers, and organizations that are representative of the
population of interest. Intersecting all aspects of the patient
engagement process in research is the learning between in-
vestigators and patients. Research on patient engagement
has rarely incorporated qualitative research methods that
involve participants in the research process [2]. The current
report details the results of a qualitative interview and ob-
servational study that examined what investigators, re-
search managers, and patients learned from working
together on research teams. An overview of the literature
on the topic of stakeholder engagement in medical research
was conducted and is included in the background section
to give context to this research. This study focused on a
central and important aspect of this engagement process:
learning between investigators and patients.
There has been rising interest in patient and stakeholder
engagement in clinical research over the past 10 years [3].
Much of this research has focused on ways to engage
stakeholders, logistical arrangements needed to involve
patients, and issues such as making sure patients under-
stand medical and research terminology. With this basic
research completed it is time to focus attention on the
deeper issues involved when investigators and patients
work together on research projects. An appraisal of the lit-
erature on engaging patients with rare diseases in research
found 35 studies. However, none of the studies included
an “empirical assessment of engagement practices and
their effectiveness” [4]. Using a case study methodology,
researchers identified several key principles necessary for
patient engagement in research endeavors, including: en-
sure balance in participating stakeholders, obtain partici-
pant “buy-in” to the process and understanding of their
roles, provide neutral and expert facilitators for
research discussions, establish connections between
participants, and keep participants engaged through-
out the research process [5]. Another systemic review
of research on patient engagement included 142 stud-
ies and concluded that “patient engagement increased
study enrollment rates and aided researchers in secur-
ing funding, designing study protocols and choosing
relevant outcomes” [6]; these authors concluded that
the most commonly cited challenges were the need
for funding to involve patients and the “overarching
worry of a tokenistic engagement” of patients [6]. A
study most closely related to the current research ex-
amined the language of engagement [7]. “We learned
that fruitful collaborative work must attend to the
creation of a common language, which we refer to as
the language of engagement”. “We encourage other re-
searchers to think critically about their cultural com-
petency, to be mindful of the social power dynamics
between patient and physician, to reflect on how their
understanding may differ from those of their patient
partners …”.
A report on patient engagement issued by the [8] em-
phasized the need for consistent terminology, and the
need to engage stakeholders early and to maintain rela-
tionships, being flexible about the methods of engagement
[8]. Another study that includes clear recommendations
for patient engagement emphasized that the engagement
needs to be “bi-directional between stakeholders and re-
searchers” and emphasized that “… researchers and stake-
holders should be committed to the process at the outset;
neutral and expert facilitators should be used to guide re-
search discussions; connections among stakeholders
should be encouraged; and an environment of mutual re-
spect should be fostered” [9].
Few studies have examined patient engagement from
the patients’ perspective. One study that did undertake
this focus found that patients were concerned that the
process of discussion and deliberation be fair, that pa-
tients’ perspectives be taken seriously, and that token-
ism be avoided at all costs [10]. The concern about
tokenism appears in other research studies on patient
engagement [11].
Much of the literature on patient engagement in
medical research is prescriptive, and includes learn-
ings from researchers’ experience with involving pa-
tients. The existing quantitative or qualitative work in
this area is often based on small samples. Only a few
studies have closely examined how to develop pro-
ductive relationships between investigators [12] and
patients when involving patients in the research
process. The current study sought to further this
examination by looking at the relationships that de-
veloped between investigators and patient-partners
over an 18-month period.
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Methods
This qualitative study examined the results of 18 months
of data collection for a project, funded by the PCORI in
which patient-partners, physician investigators, PhD in-
vestigators, and managers worked on teams building a
network of patients for future research projects, to re-
view plans, ideas, and protocols for research studies, and
to generate ideas for future research endeavors.
The Vasculitis Patient-Powered Research Network
Vasculitis is a set of rare organ- and life-threatening
diseases of vascular inflammation linked by similar path-
ophysiologies. Despite improvement in the overall prog-
nosis of vasculitis since the introduction of regimens
based on combination immunosuppressive therapy, the
cumulative morbidity and mortality from both disease
and treatment for most patients, the social impact, and
the costs remain high.
The Vasculitis Patient-Powered Research Network
(VPPRN) is a collaboration among patients, patient ad-
vocacy organizations, academic clinical investigators, ex-
pert clinicians, biomedical informaticians, qualitative
and quantitative methodologists, and funding organiza-
tions, all dedicated to conducting high-quality clinical
research in vasculitis (www.vpprn.org). The VPPRN was
a founding member of the Patient-Centered Outcomes Re-
search Network (PCORnet, www.PCORnet.org). PCORnet
directly engages patients, physician-investigators, research
methodologists, and project managers to work together to
build a collaborative national resource using the partner-
ship and health data for better research [1]. Patients are
fully engaged in the management of the Network with roles
that include strategic planning, developing, reviewing, and
approving research studies.
The VPPRN embraces the collaborative, patient-cen-
tered philosophy of PCORnet and has, from the incep-
tion of the Network through its full implementation,
involved patient-partners at every level of organizational
governance and research planning. The co-principal
investigators of the VPPRN are an academic
physician-scientist and a patient-partner, and the VPPRN
is an extension of an already highly collaborative rela-
tionship among the Vasculitis Clinical Research Consor-
tium, the major vasculitis research network, and the
Vasculitis Foundation, the major patient advocacy group
for vasculitis. Additional patient-partners with vasculitis
were chosen by the patient co-PI and Vasculitis Founda-
tion staff through a competitive selection process. Train-
ing in patient participation in research was provided to
all patient-partners. Patient-partner training was developed
in collaboration with consultants from the Organizational
Dynamics Program at the University of Pennsylvania and
was provided online over multiple training sessions by the
VPPRN Network and Data managers.
The VPPRN maintains an on-line research registry
through which patients with all forms of vasculitis
provide clinical data about their condition. The type of
information collected through the VPPRN portal in-
cludes data elements relevant to diagnosis, disease ex-
tent, medications, demographics, healthcare team, and
patient-reported outcomes. Member patients in the
VPPRN have consented specifically to take part in re-
search activities.
Interviews
All patients, physician-investigators, and managers
who had participated in the VPPRN governance since
2014 were invited to participate in the study; a total
of 22 interviews were conducted. Because of the
differences in status and authority (actual or perceived)
between patients and physician-investigators, the study
was interested in understanding how patients,
physician-investigators, PhD-investigators, and study staff
worked together. All participants in this study, including
patient-partners, investigators, and study staff provided in-
formed consent to participate in the interviews and obser-
vations, and to have their data used for publication.
Thirteen of 17 patient-partners involved in the Network
governance structure participated in this project in 2015–
2016 and were interviewed about what they learned from
working on teams with physician-investigators. Four of 6
physician/PhD-investigators involved in the network gov-
ernance structure participated in this project and were
interviewed about what they learned from working on
teams with patients. The 3 research managers (Network
Manager, Project Manager, and Data Manager) were inter-
viewed about what they learned from working on teams
with both patients and investigators.
The interviews were conducted using an internet-
based conference system and were recorded to ensure
accuracy. The interviews were transcribed for coding.
Interviewees were asked 11 questions. The questions
ranged from what they have found to be most exciting
about working on teams with investigators and patients
to specific questions about what the interviewees learned
from working with those outside of their identity group.
Emerging themes and the researchers’ impressions re-
garding the interactions between physician-investigators
and patients, boundaries, norms, roles, leadership and
decision-making were documented.
In-person meetings and teleconference calls
The rich interview data was supplemented with the ob-
servational data. The use of observational and interview
data helped to gain a deeper understanding of what
physician-investigators and patients are learning from
working together. Participant researchers attended a
total of 74 meetings, 6 were in-person and the rest were
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by web-conferencing. Official minutes and participant
researchers’ observational notes from the 6 in-person
meetings and 42 telephone/web-conference meetings
were reviewed and coded. Of the 74 meetings the par-
ticipant researchers attended, 42 were chosen for review
and coding. These 42 meetings were chosen for analysis
as 2 or more patient-partners participated. Since the
focus of this research is on what investigators and
patient-partners learn from working together, only the
meetings with 2 or more patient-partners involved were
included in the analysis.
Data analysis
The interview and meeting transcripts were reviewed
and coded for emergent themes, insights, and patterns,
and analyzed utilizing a hybrid method of coding. There
were three researchers coding the meetings independ-
ently. The hybrid approach included incorporating a
priori codes derived from literature references and open,
emergent codes arising in the data that were different
from the pre-set codes. The same method of coding was
applied to the observational documents until data satur-
ation was reached. For the purposes of this research,
data saturation was met after the coding of 42 of the
meetings and the 13 interviews. The coding scheme was
refined and each category defined by breaking down
flourishing codes into sub-codes and collapsing other
codes into larger themes. Final codes and categories
were transferred into a data table.
Results
Patient-partner characterization of their working relationships
with investigators
When asked about how patient-partners characterized
their working relationships with the investigators, over
half were positive [5], while 6 had some critical assess-
ments. For teams to work effectively, for trust and learn-
ing to occur, members need to feel positive about their
working relationships with others on the team. Over half
of the patient-partners characterized their relationship
with investigators in a fully positive manner and an al-
most equal number characterized their relationship as
moderately positive. Feedback for improvement was
garnered from all patient-partners. A patient-partner
suggests, “It is important to be explicit about the expec-
tations; due dates for deliverables need to be firm and
the outcome of each deliverable needs to be well
described.”
The VPPRN fosters a group culture in which stake-
holders are empowered with responsibility over Network
activities, and are given the tools to maximally contrib-
ute to the groups’ goals. Feedback from participants indi-
cated that such empowerment is appreciated but could
be expanded upon. Although, patients, clinicians,
investigators and other stakeholders may each play dif-
ferent roles at times in Network management, and Net-
work members have varied expertise, all views need
space to be shared and are important to consider in the
work of the VPPRN.
What patient-partners learned from working with
investigators
Patients’ responses provided few specifics about what
they learned from investigators and managers. The
lack of specificity is attributed to the task emphasis
in the working teams in the Network. To maximize
efficiency and capitalize on limited meeting time, the
teams focused on the deliverables under their charter.
The participants felt that the considerable milestones
and time constraints afforded the teams little time to
explore each other’s areas of expertise. The
patient-partners valued the commitment and contri-
butions of the investigators and managers. Conse-
quently, they had few criticisms about the other
stakeholders on the teams; they were more specific in
discussing the barriers they experienced in learning
from investigators and managers.
Patient-partners’ recommendations for future teams of
patient-partners and investigators
The recommendations that patient-partners made for fu-
ture teams undertaking this type of work centered
mainly on improvements to communication methodolo-
gies. Four of the patient-partners expressed difficulty
with meetings by conference call, and not being able to
see their fellow team members. They indicated that
meetings using video and in-person meetings would help
to create rapport and build more trust. Three patient-
partners mentioned that more effort should be put into
involving patient-partners. Two patient-partners talked
about the need to set clearer expectations at the start
about what would be involved in the team’s work. More
information about how the research process works was
recommended by one patient-partner and another per-
son urged future teams to have a fuller understanding of
the whole (i.e., what other teams in the Network are
doing and working on). One person recommended that
the discussions be more open, another suggested specific
assignments between meetings, and another person em-
phasized the need for patient-partners to educate the
investigators.
Investigators and managers characterization of their
working relationships with patient partners
Investigators and managers were generally positive in
characterizing their relationships with patient-partners
on the teams they worked on. All nine investigators
and managers valued the opportunity to work with
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patient-partners. The investigators and managers noted
feelings of respect and appreciation for the insight and
knowledge patient-partners bring to inform the develop-
ment of VPPRN research protocols.
What investigators and managers learned from working
on teams with patient-partners
Investigators and managers acknowledged the need for
improvement when asked to characterize the working
relationships between them and the patient-partners. Six
investigators and managers expressed interest in working
to improve the learning environment that was created
on the teams. Investigators and managers also learned
ways in which patients’ felt heard and empowered which
can only be learned through interaction with each teams’
patient-partners. Investigators and managers also learned
the substantial importance of setting expectations and
clearly defining roles, deliverables, and timelines.
Investigators’ and managers’ recommendations for future
teams of investigators and patient-partners
The interviewees contributed a range of suggestions for
future teams that involve investigators and patients. Four
interviewees emphasized the need for recruiting patients
who have high levels of confidence and professional de-
meanor. Two interviewees emphasized the importance
of setting clear expectations at the start. One interviewee
suggested that investigators be trained on how to engage
patients in this type of collaborative endeavor. One dis-
cussed the importance of operating using clear team
guidelines and principles. Another thought it was im-
portant to make sure that everyone understood the
jargon and acronyms being used. One interviewee dis-
cussed the importance of ensuring that investigators and
patients had equal relationships on the teams.
Working relationships during team meetings
Review of notes and coding were conducted for the 42
team meetings in which 2 or more patient-partners par-
ticipated. All meetings were led by an investigator or
manager. The predominant format was for the investiga-
tor or manager to start the meeting, go over the agenda,
and then to call on team members, including the pa-
tient- partners, and ask for their input and reactions.
The resulting data indicated that investigators and
patient-partners were clearly respectful of each other; a
tone of respect and consideration was present in all 42
meetings. As further evidence of the constructive nature
of the team interactions when disagreement did occur it
was handled as a learning opportunity. There were no
instances of angry or conflictual interactions during the
42 meetings.
Incorporation of patient-partners’ ideas
There was evidence that patient-partners’ ideas were in-
corporated into the work of the Network. Each team
meeting included at least one example of a patient-part-
ner contributing an idea or reacting to an issue, and the
investigator or manager leading the meeting reinforcing
that comment positively. For example, an investigator or
manager often said, “It is very helpful that you raised
that point.”
Recommendations from patient-partners for improved
team dynamics
In four team meetings patient-partners indicated that
they wanted more information about what the other
teams in the Network were doing. In six team meetings
patient-partners indicated that they needed more time to
consider the issues being discussed, or that they felt
rushed in addressing the issues raised in the meeting.
Patient-partners indicated numerous times that they
would like to have in-person meetings to get to know
each other more fully.
Discussion
There is sufficient evidence to support the understand-
ing that establishing productive and positive partnerships
with multiple stakeholders in research development re-
quires supportive organizational policies and structure
that takes into account different power structures and
hierarchy. The purpose of this qualitative study was to
better understand what medical investigators and
patient-partners learn from each other by working on
teams together. It was based on the premise that for real
engagement and involvement to occur in groups where
members have different levels of power and status learn-
ing needs to be reciprocal [13–15]. Due to the low preva-
lence and diversity of rare diseases and resulting small
number of patients, patient communities for rare diseases
tend to be highly motivated to participate in research [16].
This motivation and willingness to participate in research
has made rare disease research a fertile space to expand
and build upon the benefits of involving patients in the
development of research protocols. Patient’s partnering in
research development traverse more traditional sociomed-
ical landscapes, intersecting, and in many cases redefining,
knowledge and power hierarchies in a research develop-
ment space.
The teams examined had the goal of creating a net-
work of patients to participate in future research studies,
gaining input from patients about the design of research
studies, and vetting ideas for future research. Re-
searchers looking at patient engagement in medical re-
search endeavors are now starting to refer to this aspect
of the work as "co-learning"[1].
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The initial goals of the VPPRN were to involve pa-
tients in enrolling patients in the Network who would
provide data for future research studies, to develop a
secure and user-friendly patient-portal for patient
involvement in the VPPRN, to review research forms
and surveys, and to vet ideas for future research studies.
The goals of the VPPRN are aligned with those of
Patient-Centered Outcomes Research Institute to engage
patients to conduct rigorous research. The VPPRN has
been highly successful in meeting all these goals. There
is strong evidence from the interviews with patient-part-
ners, investigators, managers, and observations of the
team meetings, that the interaction during the team
meetings between investigators, managers, and patient-
partners was quite positive. When disagreements
occurred, they were used as learning opportunities
and were considered constructive to the group
process. The meetings were often described as being
“respectful” and “cordial”.
In terms of learning, there is ample evidence that
patient-partners learned about medical terminology
and research issues. Investigator and manager learning
was evident in the work products of the Network and
reflexivity of team meetings and procedures. Investi-
gators and managers emphasized the need to set ex-
pectations and clearly define roles, a theme that
emerged from working with patient-partners and
learning about their needs in order to meaningfully
engage patient-partners. The format of the team
meetings, which were led by a manager or investiga-
tor, indicates an area for improvement in collabor-
ation. Based on the research on collaboration, shared
leadership between patient-partners, investigators, and
managers is expected. The structure of the initial
meeting leadership may have been more indicative of
the newness of the Network and respect for patient-
partners’ time commitment. The opportunity to im-
prove balance between collaboration, time commit-
ments, and roles surfaced periodically.
Another important learning from this work is that
both patients and investigators are eager to work to-
gether and power differences and hierarchies can be
bridged. Patients on the teams studied consistently indi-
cated that having a voice in research studies and future
research made them feel that they were making a posi-
tive contribution. For patients who sometimes feel iso-
lated or inconsequential this boosted their confidence
and helped them to see that their knowledge about their
disease could benefit others. Investigators consistently
appreciated hearing the patient’s perspective and this
contributed to their understanding of how to best pro-
tect patient’s confidentiality, to increase their likelihood
of understanding and completing surveys, and how pa-
tient’s view future research priorities.
Conclusion
While there is ample evidence that the VPPRN teams
met their task goals, there are opportunities to improve
shared learning between investigators and patients.
Co-learning is essential for future efforts to increase pa-
tient engagement. A good deal of evidence exits about
how to recruit and organize patient involvement in re-
search endeavors. A next important step could be to de-
velop methods to more deeply engage patients and
investigators in learning from each other. This study is
an important step in that direction, and there is a need
for additional studies which probe more deeply into the
factors that encourage engagement, trust, and learning
between patients and investigators. Such work will
hopefully lead to a healthy and positive transform-
ation in how health care research is conceived, de-
signed, and conducted.
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